Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1965 2
1966 3
1967 1
1968 4
1969 5
1970 5
1971 5
1972 4
1973 2
1974 7
1975 4
1976 5
1977 3
1978 3
1979 7
1980 6
1981 4
1982 15
1983 5
1984 10
1985 6
1986 11
1987 12
1988 9
1989 26
1990 20
1991 18
1992 24
1993 23
1994 22
1995 20
1996 19
1997 26
1998 14
1999 22
2000 25
2001 33
2002 19
2003 31
2004 39
2005 44
2006 32
2007 28
2008 41
2009 42
2010 40
2011 41
2012 42
2013 50
2014 48
2015 37
2016 57
2017 50
2018 62
2019 49
2020 50
2021 58
2022 51
2023 44
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,264 results

Results by year

Filters applied: . Clear all
Page 1
Cutaneous Lupus Erythematosus: Progress and Challenges.
Petty AJ, Floyd L, Henderson C, Nicholas MW. Petty AJ, et al. Curr Allergy Asthma Rep. 2020 Apr 4;20(5):12. doi: 10.1007/s11882-020-00906-8. Curr Allergy Asthma Rep. 2020. PMID: 32248318 Free PMC article. Review.
PURPOSE OF REVIEW: The review provides an update on the diagnosis, pathogenesis, and treatment of cutaneous lupus erythematosus (CLE). RECENT FINDINGS: Diagnostic challenges exist in better defining CLE as an independent disease distinct from systemic lupu
PURPOSE OF REVIEW: The review provides an update on the diagnosis, pathogenesis, and treatment of cutaneous lupus erythemat
Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspects.
Vale ECSD, Garcia LC. Vale ECSD, et al. An Bras Dermatol. 2023 May-Jun;98(3):355-372. doi: 10.1016/j.abd.2022.09.005. Epub 2023 Mar 1. An Bras Dermatol. 2023. PMID: 36868923 Free PMC article. Review.
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusively cutaneous disease or be one of the multiple manifestations of systemic lupus erythematosus. ...This review proposes
Cutaneous lupus erythematosus is an autoimmune disease of varied clinical expression, which may present as an exclusive
Cutaneous lupus erythematosus: diagnosis and treatment.
Okon LG, Werth VP. Okon LG, et al. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):391-404. doi: 10.1016/j.berh.2013.07.008. Best Pract Res Clin Rheumatol. 2013. PMID: 24238695 Free PMC article. Review.
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be associated with the development of systemic disease. ...CCLE includes discoid lupus erythematosus (DLE), LE profundus (LEP), chi
Cutaneous lupus erythematosus (CLE) encompasses a wide range of dermatologic manifestations, which may or may not be as
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Niebel D, de Vos L, Fetter T, Brägelmann C, Wenzel J. Niebel D, et al. Am J Clin Dermatol. 2023 Jul;24(4):521-540. doi: 10.1007/s40257-023-00774-8. Epub 2023 May 4. Am J Clin Dermatol. 2023. PMID: 37140884 Free PMC article. Review.
Lupus erythematosus comprises a spectrum of autoimmune diseases that may affect various organs (systemic lupus erythematosus [SLE]) or the skin only (cutaneous lupus erythematosus [CLE]). ...A close interdisciplinary exchange with
Lupus erythematosus comprises a spectrum of autoimmune diseases that may affect various organs (systemic lupus eryth
Cutaneous lupus erythematosus: issues in diagnosis and treatment.
Walling HW, Sontheimer RD. Walling HW, et al. Am J Clin Dermatol. 2009;10(6):365-81. doi: 10.2165/11310780-000000000-00000. Am J Clin Dermatol. 2009. PMID: 19824738 Review.
Cutaneous lupus erythematosus (LE) may present in a variety of clinical forms. Three recognized subtypes of cutaneous LE are acute cutaneous LE (ACLE), subacute cutaneous LE (SCLE), and chronic cutaneous LE (CCLE). ...
Cutaneous lupus erythematosus (LE) may present in a variety of clinical forms. Three recognized subtypes of cutaneou
Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist.
Stull C, Sprow G, Werth VP. Stull C, et al. J Rheumatol. 2023 Jan;50(1):27-35. doi: 10.3899/jrheum.220089. Epub 2022 Sep 15. J Rheumatol. 2023. PMID: 36109075 Free PMC article. Review.
The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations at some point in their disease course. The skin findings in SLE are classified as SLE-specific or SLE-nonspecific based on histopathologic findings. SLE-specific sk …
The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations at some point in their d …
A Systematic Review of the Progression of Cutaneous Lupus to Systemic Lupus Erythematosus.
Curtiss P, Walker AM, Chong BF. Curtiss P, et al. Front Immunol. 2022 Mar 11;13:866319. doi: 10.3389/fimmu.2022.866319. eCollection 2022. Front Immunol. 2022. PMID: 35359921 Free PMC article. Review.
Many patients present with cutaneous lupus, where disease is often limited to the skin, but are at risk for developing systemic lupus. The objective of our present study is to perform a systematic review of studies that investigated patient cohorts and popula …
Many patients present with cutaneous lupus, where disease is often limited to the skin, but are at risk for developing systemi …
Drug-induced lupus erythematosus: an update on drugs and mechanisms.
He Y, Sawalha AH. He Y, et al. Curr Opin Rheumatol. 2018 Sep;30(5):490-497. doi: 10.1097/BOR.0000000000000522. Curr Opin Rheumatol. 2018. PMID: 29870500 Free PMC article. Review.
RECENT FINDINGS: A large number of proton pump inhibitor (PPI)-induced subacute cutaneous lupus erythematosus cases have been reported, suggesting a shift over time in the spectrum of drugs implicated in DILE. ...Chemotherapeutic drugs were the most common dr …
RECENT FINDINGS: A large number of proton pump inhibitor (PPI)-induced subacute cutaneous lupus erythematosus cases hav …
Cutaneous lupus erythematosus: clinico-pathologic correlation.
Filotico R, Mastrandrea V. Filotico R, et al. G Ital Dermatol Venereol. 2018 Apr;153(2):216-229. doi: 10.23736/S0392-0488.18.05929-1. Epub 2018 Jan 24. G Ital Dermatol Venereol. 2018. PMID: 29368845 Free article. Review.
Cutaneous lupus erythematosus (CLE) is a chronic-relapsing disease. ...A fourth variety is the intermittent form (ICLE) also called "lupus tumidus" (LET) which is considered by some authors a distinct form from CCLE. ...
Cutaneous lupus erythematosus (CLE) is a chronic-relapsing disease. ...A fourth variety is the intermittent form (ICLE)
Chilblains in immune-mediated inflammatory diseases: a review.
Dubey S, Joshi N, Stevenson O, Gordon C, Reynolds JA. Dubey S, et al. Rheumatology (Oxford). 2022 Nov 28;61(12):4631-4642. doi: 10.1093/rheumatology/keac231. Rheumatology (Oxford). 2022. PMID: 35412601 Free PMC article. Review.
Chilblains were first described over a hundred years ago as cutaneous inflammatory lesions, typically on the digits, occurring on cold exposure. Chilblains can be primary, or secondary to a number of conditions such as infections, including COVID-19, and immune-mediated in …
Chilblains were first described over a hundred years ago as cutaneous inflammatory lesions, typically on the digits, occurring on col …
1,264 results